| 000 | 01354 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513123944.0 | ||
| 264 | 0 | _c19970918 | |
| 008 | 199709s 0 0 eng d | ||
| 022 | _a0007-1048 | ||
| 024 | 7 |
_a10.1046/j.1365-2141.1997.2113028.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPu, Q Q | |
| 245 | 0 | 0 |
_aInterleukin-4 prevents spontaneous in-vitro apoptosis in chronic lymphatic leukaemia but sensitizes B-CLL cells to melphalan cytotoxicity. _h[electronic resource] |
| 260 |
_bBritish journal of haematology _cAug 1997 |
||
| 300 |
_a413-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xtoxicity |
| 650 | 0 | 4 |
_aApoptosis _xphysiology |
| 650 | 0 | 4 |
_aB-Lymphocytes _xpathology |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-4 _xpharmacology |
| 650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xpathology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelphalan _xtoxicity |
| 650 | 0 | 4 | _aMiddle Aged |
| 700 | 1 | _aBezwoda, W R | |
| 773 | 0 |
_tBritish journal of haematology _gvol. 98 _gno. 2 _gp. 413-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2141.1997.2113028.x _zAvailable from publisher's website |
| 999 |
_c9246526 _d9246526 |
||